OCT 19, 2017 05:55 AM PDT

Scientists Discover "Block-and-Lock" Drug to Cure HIV

WRITTEN BY: Kara Marker

For the first time, researchers dare to suggest they may have found a functional cure for HIV, the viral infection that leads to AIDS: a new drug used in combination with existing antiretroviral treatment stops HIV in its tracks. The remarkable study describing this discovery was recently published in the journal Cell Reports.

Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte. Credit: CDC

From the Scripps Research Institute, scientists introduce a derivative of a natural compound called didehydro-Cortistatin A (dCA). The dCA derivative works by blocking a transcriptional activator called Tat in virally-infected cells. Without Tat, viruses can’t replicate. If viruses can’t replicate, they can’t cause disease.

According to study leader Susana Valente, this is the first-ever treatment approach to completely halt viral production in infected cells.

"This is the only class of drugs that stops infected cells from making viruses outright," Valente explained. "All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production."

The new drugs works as a “Block-and-Lock” approach. It prevents latent viruses from “waking up” and causing future infection. And why combine it with existing antiretroviral drugs? "Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation," Valente explained.

HIV is infamous for hiding in cells, remaining dormant until treatment stops, only to resurface and cause an infection even worse than before. The new drug stops the resurfacing, and in new studies applying the maximum tolerable dose of the drug, Valente sees “virtually no side effects.”

Researchers from the SRI tested the new combination therapy in a mouse model of a latent and persistent HIV infection. Mice were given one month of treatment, and latent viruses continued to be “blocked and locked” for 19 days after treatment stopped. To put things into perspective, for mice who only received antiretroviral drugs, the virus “came back to life” within a week of the drugs stopping.

"This study shows that a 'functional cure' approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption,” explained co-first author Cari F. Kessing.

The results Valente and her team saw were promising given the treatment was only administered for a month. But what could the benefits be when treatment continued for a longer period of time?

“The question is, how long?” Valente said. “We're studying that now."

Source: Scripps Research Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 26, 2018
Cardiology
NOV 26, 2018
Can beet juice 'de-stiffen' the arteries?
If you’ve been drinking beet juice before going to the gym, the results of a new study may surprise you.   Image Credit: "beet juice"...
NOV 21, 2018
Cardiology
NOV 21, 2018
What We Know About Kawasaki Disease
Kawasaki disease discovered by Dr. Tomisaku Kawasaki, a Japanese pediatrician, is a rare type of vasculitis, or inflammation of the blood vessels. It&rsquo...
NOV 25, 2018
Health & Medicine
NOV 25, 2018
Why Does E. Coli Make us Sick?
  Escherichia coli, or E. coli refer to a diverse group of of bacteria commonly found in the lower intestine of warm blooded animals. While E. coli ga...
NOV 28, 2018
Microbiology
NOV 28, 2018
A Deadly Microbe Lurks on the Skin of Many People
There are some well-known bacterial pathogens that can present a major threat to health, but a lesser-known microbe may be just as big of a danger....
DEC 04, 2018
Immunology
DEC 04, 2018
Natural HIV Resistance
A team of scientists discover unique immune reactions to the one percent of HIV infected patients that are able to fend off viral propagation without antiretroviral therapy...
DEC 11, 2018
Immunology
DEC 11, 2018
Penetrating Brain Tumors
A team of researchers reveals potential targets for glioma tumors....
Loading Comments...